Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time

Overview of attention for article published in World Journal of Urology, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#43 of 2,184)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 50 X posts from 40 X users, with an upper bound of 157,835 followers.

RT @wjurol: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains…

RT @wjurol: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains…

RT @wjurol: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains…

RT @wjurol: Despite the promise of liquid biopsy-derived miRNAs as cancer biomarkers, their validation and clinical implementation remains…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 46 additional X posts.